Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D D Richman

Showing results (31-40 of 314) with videos related to

Pageof 32
Sort By:
Scientific American|July 2, 1998
How drug resistance arisesD D Richman
Current Topics in Microbiology and Immunology|January 1, 1992
Selection of zidovudine-resistant variants of human immunodeficiency virus by therapyD D Richman
Reviews of Infectious Diseases|July 1, 1990
Zidovudine resistance of human immunodeficiency virusD D Richman
Infectious Disease Clinics of North America|June 1, 1988
The treatment of HIV infection. Azidothymidine (AZT) and other new antiviral drugsD D Richman
Nature|February 18, 1993
Human immunodeficiency virus. Playing chess with reverse transcriptaseD D Richman
Drugs|January 1, 1995
Early versus delayed treatment of HIV infection. Zidovudine should be given before symptoms developD D Richman, D Havlir
The American Journal of Medicine|August 29, 1988
Results of continued monitoring of participants in the placebo-controlled trial of zidovudine for serious human immunodeficiency virus infectionD D Richman, J Andrews
Advances in Experimental Medicine and Biology|January 1, 1995
The role of surface CD4 in HIV-induced apoptosisJ Corbeil, D D Richman
The Journal of General Virology|March 1, 1995
Productive infection and subsequent interaction of CD4-gp120 at the cellular membrane is required for HIV-induced apoptosis of CD4+ T cellsJ Corbeil, D D Richman
Antiviral Therapy|August 1, 1996
Can HIV infection be cured?J M Lange, D D Richman
Pageof 32

Showing results (31-40 of 314) with videos related to

Sort By:
Pageof 32
Scientific American|July 2, 1998
How drug resistance arisesD D Richman
Current Topics in Microbiology and Immunology|January 1, 1992
Selection of zidovudine-resistant variants of human immunodeficiency virus by therapyD D Richman
Reviews of Infectious Diseases|July 1, 1990
Zidovudine resistance of human immunodeficiency virusD D Richman
Infectious Disease Clinics of North America|June 1, 1988
The treatment of HIV infection. Azidothymidine (AZT) and other new antiviral drugsD D Richman
Nature|February 18, 1993
Human immunodeficiency virus. Playing chess with reverse transcriptaseD D Richman
Drugs|January 1, 1995
Early versus delayed treatment of HIV infection. Zidovudine should be given before symptoms developD D Richman, D Havlir
The American Journal of Medicine|August 29, 1988
Results of continued monitoring of participants in the placebo-controlled trial of zidovudine for serious human immunodeficiency virus infectionD D Richman, J Andrews
Advances in Experimental Medicine and Biology|January 1, 1995
The role of surface CD4 in HIV-induced apoptosisJ Corbeil, D D Richman
The Journal of General Virology|March 1, 1995
Productive infection and subsequent interaction of CD4-gp120 at the cellular membrane is required for HIV-induced apoptosis of CD4+ T cellsJ Corbeil, D D Richman
Antiviral Therapy|August 1, 1996
Can HIV infection be cured?J M Lange, D D Richman
Pageof 32